To include your compound in the COVID-19 Resource Center, submit it here.

Valeant Pharmaceuticals, Sanitas Group deal

Valeant will acquire Lithuanian branded generics company Sanitas for about €314 million ($440.2 million) in cash. Valeant

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE